Cypress Wealth Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,754
Closed -$343K 211
2017
Q1
$343K Buy
2,754
+40
+1% +$4.79K 0.16% 124
2016
Q4
$314K Buy
2,714
+673
+33% +$74.9K 0.14% 129
2016
Q3
$213K Buy
+2,041
New +$221K 0.1% 182
2016
Q2
Sell
-2,222
Closed -$222K 214
2016
Q1
$222K Sell
2,222
-294
-12% -$30.3K 0.1% 168
2015
Q4
$301K Buy
2,516
+435
+21% +$50.3K 0.15% 126
2015
Q3
$225K Buy
+2,081
New +$258K 0.12% 158

Other funds holding CELG

Cypress Wealth Advisors's CELG Position: Q2 2017 in Review

Cypress Wealth Advisors sold out of Celgene Corp (CELG) in Q2 2017, closing a stake of 2,754 shares — an estimated $343K sold.

Cypress Wealth Advisors first reported a position in CELG in Q3 2015 and held it in 6 quarters. The position peaked at $343K in Q1 2017. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

  • Cypress Wealth Advisors reported no remaining Celgene Corp position as of Q2 2017 after selling out during the quarter.
  • Cypress Wealth Advisors sold 2,754 Celgene Corp shares in Q2 2017, an estimated $343K.
  • Cypress Wealth Advisors first reported a position in Celgene Corp in Q3 2015 and held it in 6 quarters.
  • Cypress Wealth Advisors's Celgene Corp position peaked at $343K in Q1 2017.
  • 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Cypress Wealth Advisors's 13F filing for Q2 2017, filed 16 Aug 2017.